Healthy volunteers needed to compare two survodutide formulas

This study tests a new formulation of survodutide, a medicine being developed for obesity and liver conditions. About 100 healthy adults aged 18-65 with a BMI between 27 and 40 will receive weekly injections of either the current or new formula for 28 weeks. Researchers will measure how much drug gets into the blood and monitor for side effects. This is a phase 1 trial, so it focuses on drug absorption and safety, not treatment.